WallStreetZenWallStreetZen

NASDAQ: NEOG
Neogen Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for NEOG

Based on 2 analysts offering 12 month price targets for Neogen Corp

Min Forecast
$5.00-9.58%
Avg Forecast
$9.00+62.75%
Max Forecast
$13.00+135.08%

Should I buy or sell NEOG stock?

Based on 2 analysts offering ratings for Neogen Corp.

Buy
Strong Buy
1 analysts 50%
Buy
0 analysts 0%
Hold
1 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although NEOG's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates NEOG as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their NEOG stock forecasts and price targets.

NEOG stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-04-22
lockedlocked$00.00+00.00%2025-04-10

1 of 1

Forecast return on equity

Is NEOG forecast to generate an efficient return?

Company
3.47%
Industry
-0.55%
Market
67.39%
NEOG's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is NEOG forecast to generate an efficient return on assets?

Company
2.29%
Industry
12.51%
NEOG is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NEOG earnings per share forecast

What is NEOG's earnings per share in the next 2 years based on estimates from 2 analysts?

Avg 1 year Forecast
$0.37
Avg 2 year Forecast
$0.43

NEOG revenue forecast

What is NEOG's revenue in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
$890.0M-1.77%
Avg 2 year Forecast
$909.3M+0.36%
NEOG's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

NEOG revenue growth forecast

How is NEOG forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
0.18%
Industry
5.17%
Market
9.85%
NEOG's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NEOG's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NEOG vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
NEOG$5.53$9.00+62.75%Buy
OPK$1.33$2.63+97.37%Buy
CDNA$18.59$28.75+54.65%Buy
GRAL$41.31$31.50-23.75%Buy
NEO$7.07$10.92+54.41%Buy
View Top Diagnostic & Research Stocks

Neogen Stock Forecast FAQ

Is Neogen Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: NEOG) stock is to Buy NEOG stock.

Out of 2 analysts, 1 (50%) are recommending NEOG as a Strong Buy, 0 (0%) are recommending NEOG as a Buy, 1 (50%) are recommending NEOG as a Hold, 0 (0%) are recommending NEOG as a Sell, and 0 (0%) are recommending NEOG as a Strong Sell.

If you're new to stock investing, here's how to buy Neogen stock.

What is NEOG's earnings growth forecast for 2026-2027?

(NASDAQ: NEOG) Neogen's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 23.18%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.71%.

Neogen's earnings in 2025 is -$485,263,000.On average, 2 Wall Street analysts forecast NEOG's earnings for 2026 to be $80,304,159, with the lowest NEOG earnings forecast at $78,133,776, and the highest NEOG earnings forecast at $82,474,541.

In 2027, NEOG is forecast to generate $92,241,263 in earnings, with the lowest earnings forecast at $91,156,072 and the highest earnings forecast at $93,326,455.

What is NEOG's revenue growth forecast for 2026-2027?

(NASDAQ: NEOG) Neogen's forecast annual revenue growth rate of 0.18% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.17%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.85%.

Neogen's revenue in 2025 is $905,996,000.On average, 3 Wall Street analysts forecast NEOG's revenue for 2026 to be $193,156,027,214, with the lowest NEOG revenue forecast at $192,860,204,056, and the highest NEOG revenue forecast at $193,533,022,684.

In 2027, NEOG is forecast to generate $197,352,896,183 in revenue, with the lowest revenue forecast at $195,160,809,686 and the highest revenue forecast at $199,588,390,333.

What is NEOG's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: NEOG) forecast ROA is 2.29%, which is lower than the forecast US Diagnostics & Research industry average of 12.51%.

What is NEOG's Price Target?

According to 2 Wall Street analysts that have issued a 1 year NEOG price target, the average NEOG price target is $9.00, with the highest NEOG stock price forecast at $13.00 and the lowest NEOG stock price forecast at $5.00.

On average, Wall Street analysts predict that Neogen's share price could reach $9.00 by Apr 22, 2026. The average Neogen stock price prediction forecasts a potential upside of 62.75% from the current NEOG share price of $5.53.

What is NEOG's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: NEOG) Neogen's current Earnings Per Share (EPS) is -$2.23. On average, analysts forecast that NEOG's EPS will be $0.37 for 2026, with the lowest EPS forecast at $0.36, and the highest EPS forecast at $0.38. In 2027, NEOG's EPS is forecast to hit $0.43 (min: $0.42, max: $0.43).

What is NEOG's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: NEOG) forecast ROE is 3.47%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.